Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds Revive to source naturally-derived psychedelic compounds, such as psilocybin for use in future investigational new drug
KABN North America and BOON Rewards Set to Launch Cashback and Rewards Programs... KABN North America and BOON Rewards Set to Launch Cashback and Rewards Programs Spanning 11.5 Million Canadian Customers...
DigiMax and DataNavee Developing AI Driven Investment Mapping and Customized Investment Analytics... DigiMax and DataNavee Developing AI Driven Investment Mapping and Customized Investment Analytics Model for Issuers and Investors
